TP53 and leukemia: In searching for other gene mutations that collaborate with JAK2V617F to drive leukemia cell transformation, we recently found that JAK2V617F and loss-function mutation of tumor suppressor p53 co-exist in two well-studied leukemia cell lines, namely, HEL and SET2 [16].